Jazz Pharmaceuticals PLC (JAZZ) — Tangible Net Worth Ratio
Jazz Pharmaceuticals PLC (JAZZ) has a Tangible Net Worth Ratio of 7.2% as of March 2026. This metric is calculated by deducting intangible assets ($4.20 Billion) from net assets ($4.53 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See JAZZ book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Jazz Pharmaceuticals PLC Tangible Net Worth Ratio (2007–2025)
This chart shows how Jazz Pharmaceuticals PLC's Tangible Net Worth Ratio has changed across 17 annual periods from 2007 to 2025. As of March 2026, the ratio stands at 7.2%, reflecting net assets of $4.53 Billion with intangible assets of $4.20 Billion USD. Also explore net asset growth rate of Jazz Pharmaceuticals PLC to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Jazz Pharmaceuticals PLC (2007–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Jazz Pharmaceuticals PLC from 2007 to 2025, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Jazz Pharmaceuticals PLC (JAZZ) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -2.6% | $4.32 Billion | $4.43 Billion | $11.66 Billion | ▲ +13.6 pp |
| 2024 | -16.2% | $4.09 Billion | $4.76 Billion | $12.01 Billion | ▲ +28.8 pp |
| 2023 | -45.0% | $3.74 Billion | $5.42 Billion | $11.39 Billion | ▲ +42.8 pp |
| 2022 | -87.8% | $3.09 Billion | $5.79 Billion | $10.84 Billion | ▼ -7.4 pp |
| 2021 | -80.4% | $3.97 Billion | $7.15 Billion | $12.30 Billion | ▼ -120.4 pp |
| 2020 | 40.0% | $3.66 Billion | $2.20 Billion | $6.54 Billion | ▲ +18.5 pp |
| 2019 | 21.5% | $3.11 Billion | $2.44 Billion | $5.54 Billion | ▲ +20.6 pp |
| 2018 | 0.9% | $2.76 Billion | $2.73 Billion | $5.20 Billion | ▲ +10.8 pp |
| 2017 | -9.8% | $2.71 Billion | $2.98 Billion | $5.12 Billion | ▲ +50.6 pp |
| 2016 | -60.4% | $1.88 Billion | $3.01 Billion | $4.80 Billion | ▼ -86.3 pp |
| 2015 | 25.8% | $1.60 Billion | $1.19 Billion | $3.36 Billion | ▲ +30.7 pp |
| 2014 | -4.8% | $1.37 Billion | $1.44 Billion | $3.34 Billion | ▼ -42.1 pp |
| 2013 | 37.3% | $1.30 Billion | $812.40 Million | $2.24 Billion | ▲ +14.9 pp |
| 2012 | 22.4% | $1.12 Billion | $869.95 Million | $1.97 Billion | ▼ -70.0 pp |
| 2011 | 92.4% | $192.79 Million | $14.59 Million | $253.57 Million | ▲ +64.6 pp |
| 2010 | 27.9% | $30.55 Million | $22.03 Million | $135.73 Million | ▼ -6.6 pp |
| 2007 | 34.5% | $54.99 Million | $36.04 Million | $207.55 Million | — |